Tag: Pedro Carrascal
Novartis bags Gilenya EC approval for multiple sclerosis in young patients
Gilenya EC approval : The European Commission (EC) has expanded the approval of Novartis multiple sclerosis drug Gilenya (fingolimod) to include the treatment of both ... Read More